GX-G6

· Genexine, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GX-G6, covering 2019-05-23 to 2019-05-23. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2, 12-Week, Double-Blind, Efficacy and Safety of GX-G6 in Patients With Uncontrolled Type 2 Diabetes Mellitus [Phase 2]

See pricing